Cargando…
Retraction notice for: “lncRNA ZEB1-AS1 inhibits high glucose-induced EMT and fibrogenesis by regulating the miR-216a-5p/BMP7 axis in diabetic nephropathy” [https://doi.org/10.1590/1414-431X20209288]
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
Associação Brasileira de Divulgação Científica
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10242700/ https://www.ncbi.nlm.nih.gov/pubmed/37194836 http://dx.doi.org/10.1590/1414-431X2023e9288retraction |
_version_ | 1785054272587563008 |
---|---|
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-10242700 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Associação Brasileira de Divulgação Científica |
record_format | MEDLINE/PubMed |
spelling | pubmed-102427002023-06-07 Retraction notice for: “lncRNA ZEB1-AS1 inhibits high glucose-induced EMT and fibrogenesis by regulating the miR-216a-5p/BMP7 axis in diabetic nephropathy” [https://doi.org/10.1590/1414-431X20209288] Braz J Med Biol Res Retraction Associação Brasileira de Divulgação Científica 2023-05-15 /pmc/articles/PMC10242700/ /pubmed/37194836 http://dx.doi.org/10.1590/1414-431X2023e9288retraction Text en https://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Retraction Retraction notice for: “lncRNA ZEB1-AS1 inhibits high glucose-induced EMT and fibrogenesis by regulating the miR-216a-5p/BMP7 axis in diabetic nephropathy” [https://doi.org/10.1590/1414-431X20209288] |
title | Retraction notice for: “lncRNA ZEB1-AS1 inhibits high glucose-induced EMT and fibrogenesis by regulating the miR-216a-5p/BMP7 axis in diabetic nephropathy” [https://doi.org/10.1590/1414-431X20209288] |
title_full | Retraction notice for: “lncRNA ZEB1-AS1 inhibits high glucose-induced EMT and fibrogenesis by regulating the miR-216a-5p/BMP7 axis in diabetic nephropathy” [https://doi.org/10.1590/1414-431X20209288] |
title_fullStr | Retraction notice for: “lncRNA ZEB1-AS1 inhibits high glucose-induced EMT and fibrogenesis by regulating the miR-216a-5p/BMP7 axis in diabetic nephropathy” [https://doi.org/10.1590/1414-431X20209288] |
title_full_unstemmed | Retraction notice for: “lncRNA ZEB1-AS1 inhibits high glucose-induced EMT and fibrogenesis by regulating the miR-216a-5p/BMP7 axis in diabetic nephropathy” [https://doi.org/10.1590/1414-431X20209288] |
title_short | Retraction notice for: “lncRNA ZEB1-AS1 inhibits high glucose-induced EMT and fibrogenesis by regulating the miR-216a-5p/BMP7 axis in diabetic nephropathy” [https://doi.org/10.1590/1414-431X20209288] |
title_sort | retraction notice for: “lncrna zeb1-as1 inhibits high glucose-induced emt and fibrogenesis by regulating the mir-216a-5p/bmp7 axis in diabetic nephropathy” [https://doi.org/10.1590/1414-431x20209288] |
topic | Retraction |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10242700/ https://www.ncbi.nlm.nih.gov/pubmed/37194836 http://dx.doi.org/10.1590/1414-431X2023e9288retraction |